Interestingly, other cohorts of European ancestry (Kozlitina et al., 2011; Sentinelli et al., 2011; Hyysalo et al., 2012) did not identify any significant association between APOC3 polymorphisms, NAFLD and insulin resistance. Here, APOC3 is linked to metabolic dysfunction-associated steatotic liver disease.